Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Shi YK
,
Yu YP
,
Zhu ZH
,
Han YC
,
Ren B
,
Nelson JB
,
Luo JH
.
???displayArticle.abstract???
MCM7 is a critical component of the DNA replication licensing complex that controls DNA replication in both yeast and Xenopus. Our previous studies have indicated that MCM7 is both amplified and overexpressed in metastatic prostate cancer. In this study, we found that MCM7 interacts with the androgen receptor (AR) with high affinity both in vitro and in vivo. We identified the AR-binding motif for MCM7, comprised of amino acids 221 to 248, and the MCM7-binding motif for the AR, comprised of amino acids 426 to 475. AR stimulation with high doses of the synthetic androgen R1881 led to a decrease in MCM7 binding to genomic DNA, a reduction of DNA synthesis, decreases in the number of cells progressing through S phase and cell proliferation, whereas low doses produced an increase in the DNA licensing activity of MCM7 and higher levels of cell proliferation. In addition, the MCM7/AR interaction down-regulated MCM7 expression. The gene transcription or repressor activity of AR is dependent on its interaction with MCM7 because either a mutant AR defective in its interaction with MCM7 or a MCM7 knockdown primarily eliminated AR effects on gene expression. Thus, this study reveals a novel mechanism by which AR and MCM7 facilitate each other's function, suggesting that AR-independent activation of MCM7 may be a mechanism by which prostate cancers bypass therapeutically induced AR blockade.
Blow,
Replication licensing--defining the proliferative state?
2002, Pubmed
Blow,
Replication licensing--defining the proliferative state?
2002,
Pubmed
Brake,
Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
2003,
Pubmed
Chong,
The role of MCM/P1 proteins in the licensing of DNA replication.
1996,
Pubmed
Coxon,
Fission yeast cdc21+ belongs to a family of proteins involved in an early step of chromosome replication.
1992,
Pubmed
,
Xenbase
Cunha,
The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice.
1978,
Pubmed
Dalton,
Cell cycle-regulated nuclear import and export of Cdc47, a protein essential for initiation of DNA replication in budding yeast.
1995,
Pubmed
English,
Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration.
1989,
Pubmed
Furuya,
Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation.
1993,
Pubmed
Goldstein,
Genetic and hormonal control of male sexual differentiation.
1975,
Pubmed
Heisler,
Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
1997,
Pubmed
Honeycutt,
Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
2006,
Pubmed
Ishimi,
A DNA helicase activity is associated with an MCM4, -6, and -7 protein complex.
1997,
Pubmed
Jing,
Expression of myopodin induces suppression of tumor growth and metastasis.
2004,
Pubmed
Kearsey,
The role of MCM proteins in the cell cycle control of genome duplication.
1996,
Pubmed
,
Xenbase
Levesque,
Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
2007,
Pubmed
Lin,
Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
1998,
Pubmed
Litvinov,
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
2006,
Pubmed
Litvinov,
Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.
2006,
Pubmed
Ren,
Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
2007,
Pubmed
Ren,
MCM7 amplification and overexpression are associated with prostate cancer progression.
2006,
Pubmed
Rossi,
Inhibitory effect of dihydrotestosterone on human thyroid cell growth.
1996,
Pubmed
Rossi,
Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells.
1998,
Pubmed
You,
Biochemical analysis of the intrinsic Mcm4-Mcm6-mcm7 DNA helicase activity.
1999,
Pubmed
Yu,
Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin.
2006,
Pubmed